IP Library › Granted Patent US 12,390,562
Granted Patent B2
US 12,390,562 · App. 17/179,660 · Granted Aug 19, 2025

Antimicrobial and microstatic sensor systems

Inventors: Jonathan D. McCanless (Oakland, CA); Benjamin J. Feldman (Berkeley, CA)
Assignee: ABBOTT DIABETES CARE INC.
A61L31/16A61B5/14503A61B5/6849A61L31/088A61B5/14532A61B2560/0443A61L2300/404A61L2420/02A61L2420/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,390,562
App. No.
17/179,660
Granted
Aug 19, 2025
Kind
B2
Abstract

A sensor control device and methods of making them are described. The sensor control device includes an electronics housing and a plug assembly. The electronics housing includes an upper shell matable to a lower mount having a skin-facing surface. The plug assembly is coupled to the electronics housing and includes a sensor module that has a sensor and a sharp module having a sharp. The plug assembly includes a base having a skin-facing surface and a plug portion comprising a lumen therethrough. At least a portion of a surface of the electronics housing or the plug assembly comprises an antimicrobial agent. The antimicrobial agent may be a metal and/or a metal oxide.

Claims (19)

1. A sensor control device, comprising:

a glucose sensor comprising a proximal portion configured to be positioned above a user's skin and to be electrically coupled with electronics and a distal portion configured to be transcutaneously positioned through the user's skin and in contact with a bodily fluid of the user, wherein the distal portion is configured to detect an analyte in the bodily fluid;

an electronics housing comprising an upper shell mateable to a lower mount having a skin-facing surface, wherein the electronics is disposed within the electronics housing; and

a plug assembly coupled to the electronics housing and including a sensor module that has the glucose sensor and a sharp module comprising a sharp, the plug assembly comprising a base having a skin-facing surface and a plug portion comprising a lumen therethrough,

wherein at least a portion of the skin-facing surface of the lower mount of the electronics housing or the skin-facing surface of the base of the plug assembly comprises a layer comprising titanium and a layer comprising an antimicrobial agent on the layer comprising titanium.

2. The device of claim 1 , wherein the upper shell of the electronics housing further comprises an outer perimeter lip, and wherein the outer perimeter lip further comprises the antimicrobial agent.

3. The device of claim 1 , wherein the plug portion further comprises an outward facing surface of the plug portion, an upward facing surface of the plug portion, and an exterior surface of the plug portion, an interior surface of the plug portion, and wherein at least one of the outward facing surface of the plug portion, the upward facing surface of the plug portion, the exterior surface of the plug portion, and the interior surface of the plug portion further comprises the antimicrobial agent.

4. The device of claim 1 , wherein the plug portion has a shape selected from a group consisting of frustoconical, round, and oval.

5. The device of claim 1 , wherein the antimicrobial agent is a metal or a metal oxide.

6. The device of claim 1 , wherein the antimicrobial agent is selected from the group consisting of silver, copper, zinc, and combinations thereof.

7. The device of claim 1 , wherein the antimicrobial agent is contained in a coating.

8. The device of claim 7 , wherein the antimicrobial agent is selected from a group consisting of silver, copper, zinc, and combinations thereof.

9. The device of claim 1 , wherein the antimicrobial agent comprises silver on copper or copper on silver.

10. The device of claim 1 , wherein the antimicrobial agent comprises silver and copper.

11. The device of claim 1 , wherein the antimicrobial agent is applied onto the electronics housing or the plug assembly via sputter coating to form the layer comprising the antimicrobial agent.

12. The device of claim 11 , wherein the antimicrobial agent is a metal or metal oxide.

13. The device of claim 11 , wherein the layer comprising the antimicrobial agent comprises at least 5% metal oxide by weight.

14. The device of claim 11 , wherein the layer comprising the antimicrobial agent comprises between 2% and 30% metal oxide by weight.

15. The device of claim 11 , wherein the layer comprising the antimicrobial agent has a thickness between 500 Å and 10 μm.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2021
From: MCCANLESS, JONATHAN D.; FELDMAN, BENJAMIN J.
To: ABBOTT DIABETES CARE INC.
Reel/Frame 055330/0756 →
Continuity (2)
Provisional Application 62979169 · Feb 20, 2020
Related Publication 20210260257A1 · Aug 26, 2021
References Cited (23)
US 5681575A · Burrell et al. · 1997 [cited by applicant]
US 7179849B2 · Terry · 2007 [cited by applicant]
US 20050048124A1 · Sarangapani · 2005 [cited by applicant]
US 20060141015A1 · Tessier et al. · 2006 [cited by applicant]
US 20070135699A1 · Ward et al. · 2007 [cited by applicant]
US 20080161656A1 · Bruce et al. · 2008 [cited by applicant]
US 20100285084A1 · Yang · 2010 [cited by examiner]
US 20130150691A1 · Pace et al. · 2013 [cited by applicant]
US 20140318949A1 · Wang et al. · 2014 [cited by applicant]
US 20160058380A1 · Lee et al. · 2016 [cited by applicant]
US 20160331283A1 · Rao et al. · 2016 [cited by applicant]
US 20180105927A1 · Mak et al. · 2018 [cited by applicant]
US 20190083017A1 · Walter · 2019 [cited by applicant]
JP 2011244804A · 2011 [cited by applicant]
WO WO2019222615A1 · 2019 [cited by applicant]
WO WO2019236850A1 · 2019 [cited by applicant]
WO WO2019236859A1 · 2019 [cited by applicant]
WO WO2019236876A1 · 2019 [cited by applicant]
WO, PCT/US21/18683 ISR and Written Opinion, Jun. 25, 2021. [cited by applicant]
CA, 3,166,242 Examiner's Report, May 27, 2024. [cited by applicant]
EP, 21756503.5 Extended Search Report, Jan. 31, 2024. [cited by applicant]
CN, 202180012004.X First Office Action, Mar. 3, 2025. [cited by applicant]
JP, 2022-541635 Office Action, Dec. 11, 2024. [cited by applicant]